Tianchen Medical: accumulated repurchase of 42,489.89 million shares, accounting for 3.09% of the total share capital.

Tianchen Medical announced that the company will implement a stock repurchase starting from December 27, 2023, with an expected repurchase amount of 46 million to 80 million RMB, for employee stock ownership plans or equity incentives. As of November 30, 2025, the company has repurchased a total of 2.5053 million shares, accounting for 3.09% of the total share capital, with a cumulative repurchase amount of 42.4989 million RMB, at a repurchase price ranging from 11.87 RMB to 21.00 RMB per share. In November 2025, the company did not conduct any repurchase transactions.